ⓘ Pharmaceuticals policy ..

Pharmaceutical policy

Pharmaceutical policy is a branch of health policy that deals with the development, provision and use of medications within a health care system. It embraces drugs, biologics, vaccines and natural health products. Pharmaceutical policy includes:

2006 Oregon Ballot Measure 44

Oregon ballot measure 44 was an initiated state statute ballot measure on the November 7, 2006 general election ballot. The Measure modified the eligibility requirements for Oregon residents to participate in the Oregon Prescription Drug Program. The program intends to make prescription drugs available to participants at the lowest possible cost through negotiated price discounts. It was passed overwhelmingly by voters, garnering 78% of the vote.

Access to Cannabis for Medical Purposes Regulations

The Marihuana for Medical Purposes Regulations was a set of Canadian regulations enacted in July 2013 concerning the production, distribution and use of medical cannabis. Portions of the law become effective on October 1, 2013, March 31, 2014 and March 31, 2015. The law was struck down as unconstitutional by the Federal Courts due to the inability for patients to grow their own medicine. The new act put forward is the Access to Cannabis for Medical Purposes Regulations. The MMPR program replaces the Marihuana Medical Access Regulations MMAR, which came into force on 30 July 2001. Prior to ...

American Society of Pharmacognosy

The American Society of Pharmacognosy is a scientific society that promotes the growth and development of pharmacognosy through presentation of research achievements and publication of meritorious research. ASP was founded in 1959 as an outgrowth of the Plant Science Seminar established in 1923. ASP has over 1.100 active and associate members. Approximately 40 percent of the active members reside outside the U.S. and Canada in more than 60 countries. Pharmacognosy includes the study of the physical, chemical, biochemical and biological properties of drugs, drug substances, or potential dru ...

Authorized generics

Authorized generics are prescription drugs produced by brand pharmaceutical companies and marketed under a private label, at generic prices. Authorized generics compete with generic products in that they are identical to their brand counterpart in both active and inactive ingredients; whereas according to the U.S. Food and Drug Administrations Office of Generic Drugs, generic drugs are required to contain only the identical active ingredients as the brand. Authorized generics compete with generics on price, quality and availability in the generic marketplace, and are marketed to consumers ...

Seneka Bibile

Prof. Senaka Bibile was a Sri Lankan pharmacologist. He was the founder of Sri Lankas drug policy, which was used as a model for development of policies based on rational pharmaceutical use in other countries as well by the World Health Organization, the United Nations Conference on Trade and Development and the Non-Aligned Movement. Due to the far reaching effects of his proposals and policies, he has been called the greatest medical benefactor of humanity that Sri Lanka has hitherto produced.

                                     

ⓘ Pharmaceuticals policy

  • Requirements for Registration of Pharmaceuticals for Human Use Medical cannabis National pharmaceuticals policy Vaccination policy Aggarwal, Rashmi, Kaur, Rajinder
  • Requirements for Registration of Pharmaceuticals for Human Use pharmaceutical policy Chilean pharmaceutical policy Medicare Part D Medicare Prescription
  • The Chilean Pharmaceutical Policy was an attempt in the 1960s and 1970s to introduce a rational national pharmaceuticals policy Chile was perhaps the
  • The Sri Lanka National Pharmaceuticals Policy was established in the 1970s following the submission of a report by Dr S.A. Wickremasinghe and Prof. Seneka
  • Requirements for Pharmaceuticals for Human Use ICH is an initiative that brings together regulatory authorities and pharmaceutical industry to discuss
  • domestically - developed pharmaceuticals Barnet Siu 2010 Investment conditions in China have improved due to the vast consumer demand for pharmaceuticals the lower
  • Goldacre Disease mongering Ethics in pharmaceutical sales Inverse benefit law National pharmaceuticals policy Pharmaceutical lobby Prescription Drug Marketing
  • pharmaceutical purchasing plans often referred to as rationalisation of pharmaceuticals and the development of a national pharmaceuticals policy He
  • personal healthcare policy pharmaceutical policy and policies related to public health such as vaccination policy tobacco control policy or breastfeeding
  • ever - increasing costs of pharmaceuticals The agency s primary aim is to secure for eligible people in need of pharmaceuticals the best health outcomes
  • United States et al., ex rel. Jim Conrad and Constance Conrad v. Forest Pharmaceuticals Inc, et al. involved a drug manufacturer selling a drug, Levothroid